Centre for Genomic Regulation (CRG) Featured PhD Programmes
Xi’an Jiaotong-Liverpool University Featured PhD Programmes
University of Bristol Featured PhD Programmes

Cell Biology / Development (immunology) PhD Projects, Programs & Scholarships

We have 44 Cell Biology / Development (immunology) PhD Projects, Programs & Scholarships

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


We have 44 Cell Biology / Development (immunology) PhD Projects, Programs & Scholarships

PhD saved successfully

PhD student in Immunology / Cell Biology (f/m/x)

Jobs with chances, cutting-edge medicine requires research. The position is available from 1st January 2022.  Our group works on intramembrane proteolysis which links protein degradation with signal transduction and thus represents an important regulatory mechanism for cellular homeostasis. Read more

Regulation of cancer cell metabolism by mechanical tissue cues

We are seeking applications for a fully funded PhD position in Cancer Biology and Biomechanics at Imperial College London. The Cancer Cell Protein Metabolism group in the. Read more

Investigating the effects of inflamm-aging on the safety and efficacy of monoclonal antibody based therapies

Our understanding of the immune response in the elderly is still in its infancy. Now, more than ever we need to understand the basic principles of immune response as the environment alters our immune system and the particles it sees. Read more

EASTBIO: Bioactive lipid mediators in the development and function of lung mononuclear phagocytes

  Research Group: Centre for Inflammation Research
Mononuclear phagocytes (MNPs) including macrophages and dendritic cells (DCs) play critical roles in maintenance of tissue homeostasis, inflammation, and repair post injury. Read more

Self-funded BMS project: Rewiring RNA networks to train innate anti-tumour immunity

Cancer immunotherapy has transformed outcomes in clinical oncology. Yet, challenges remain. not all types of cancer respond to current immunotherapies, and for those types that significant benefits are observed, there are still patients who show poor responses. Read more

Filtering Results